NATURE’S SUNSHINE PRODUCTS, INC. Stock Repurchase Program, Authorized Amount
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Stock Repurchase Program, Authorized Amount of $30.00 million as of 2022-03-08, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-05-07
- 2022-03-08: Stock Repurchase Program, Authorized Amount $30.00M.
- 2021-03-10: Stock Repurchase Program, Authorized Amount $15.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2022-03-08 | $30.00M 10-Q · filed 2024-05-07 |
| 2021-03-10 | $15.00M 10-Q · filed 2024-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |